114 related articles for article (PubMed ID: 33125707)
21. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
Burdick MD; Murray LA; Keane MP; Xue YY; Zisman DA; Belperio JA; Strieter RM
Am J Respir Crit Care Med; 2005 Feb; 171(3):261-8. PubMed ID: 15502109
[TBL] [Abstract][Full Text] [Related]
22. Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux.
Wang K; Zhang T; Lei Y; Li X; Jiang J; Lan J; Liu Y; Chen H; Gao W; Xie N; Chen Q; Zhu X; Liu X; Xie K; Peng Y; Nice EC; Wu M; Huang C; Wei Y
Autophagy; 2018; 14(2):269-282. PubMed ID: 29172997
[TBL] [Abstract][Full Text] [Related]
23. Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis.
Willenborg S; Eckes B; Brinckmann J; Krieg T; Waisman A; Hartmann K; Roers A; Eming SA
J Invest Dermatol; 2014 Jul; 134(7):2005-2015. PubMed ID: 24406680
[TBL] [Abstract][Full Text] [Related]
24. Role of E-selectin in bleomycin induced lung fibrosis in mice.
Azuma A; Takahashi S; Nose M; Araki K; Araki M; Takahashi T; Hirose M; Kawashima H; Miyasaka M; Kudoh S
Thorax; 2000 Feb; 55(2):147-52. PubMed ID: 10639534
[TBL] [Abstract][Full Text] [Related]
25. The effects of phycocyanin on bleomycin-induced pulmonary fibrosis and the intestinal microbiota in C57BL/6 mice.
Xie Y; Li W; Lu C; Zhu L; Qin S; Du Z
Appl Microbiol Biotechnol; 2019 Oct; 103(20):8559-8569. PubMed ID: 31473797
[TBL] [Abstract][Full Text] [Related]
26. [Effects of granulocyte colony-stimulating factor on experimental bleomycin-induced pulmonary fibrosis].
Skurikhin EG; Andreeva TV; Khmelevskaia ES; Ermolaeva LA; Pershina OV; Ermakova NN; Stepanova IE; Reztsova AM; Krupin VA; Gol'dberg VE; Reĭkhart DV; Dygaĭ AM
Eksp Klin Farmakol; 2012; 75(1):30-3. PubMed ID: 22442961
[TBL] [Abstract][Full Text] [Related]
27. CCN2 is required for bleomycin-induced skin fibrosis in mice.
Liu S; Shi-wen X; Abraham DJ; Leask A
Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632
[TBL] [Abstract][Full Text] [Related]
28. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin.
Guzy RD; Stoilov I; Elton TJ; Mecham RP; Ornitz DM
Am J Respir Cell Mol Biol; 2015 Jan; 52(1):116-28. PubMed ID: 24988442
[TBL] [Abstract][Full Text] [Related]
30. Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis.
Kabel AM; Estfanous RS; Alrobaian MM
Respir Physiol Neurobiol; 2020 Feb; 273():103316. PubMed ID: 31600583
[TBL] [Abstract][Full Text] [Related]
31. Secretoglobin 3A2 suppresses bleomycin-induced pulmonary fibrosis by transforming growth factor beta signaling down-regulation.
Kurotani R; Okumura S; Matsubara T; Yokoyama U; Buckley JR; Tomita T; Kezuka K; Nagano T; Esposito D; Taylor TE; Gillette WK; Ishikawa Y; Abe H; Ward JM; Kimura S
J Biol Chem; 2011 Jun; 286(22):19682-92. PubMed ID: 21478551
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.
Palumbo-Zerr K; Horn A; Distler A; Zerr P; Dees C; Beyer C; Selvi E; Cravatt BF; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Dec; 71(12):2051-4. PubMed ID: 22915616
[TBL] [Abstract][Full Text] [Related]
33. [Bleomycin and its cutaneous phenomena].
Wicart ML
Bull Soc Fr Dermatol Syphiligr; 1970; 77(2):198-9. PubMed ID: 5453937
[No Abstract] [Full Text] [Related]
34. Vitamin E reduces bleomycin-induced lung fibrosis in mice: biochemical and morphological studies.
Kilinç C; Ozcan O; Karaöz E; Sunguroğlu K; Kutluay T; Karaca L
J Basic Clin Physiol Pharmacol; 1993; 4(3):249-69. PubMed ID: 8679519
[TBL] [Abstract][Full Text] [Related]
35. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
36. Cryptotanshinone reverses the epithelial-mesenchymal transformation process and attenuates bleomycin-induced pulmonary fibrosis.
Zhang Q; Gan C; Liu H; Wang L; Li Y; Tan Z; You J; Yao Y; Xie Y; Yin W; Ye T
Phytother Res; 2020 Oct; 34(10):2685-2696. PubMed ID: 32281701
[TBL] [Abstract][Full Text] [Related]
37. Nephrogenic systemic fibrosis and gadolinium: a perfect storm.
Colletti PM
AJR Am J Roentgenol; 2008 Oct; 191(4):1150-3. PubMed ID: 18806157
[No Abstract] [Full Text] [Related]
38. Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis.
Cargnoni A; Ressel L; Rossi D; Poli A; Arienti D; Lombardi G; Parolini O
Cytotherapy; 2012 Feb; 14(2):153-61. PubMed ID: 21954836
[TBL] [Abstract][Full Text] [Related]
39. Parabiosis and transplantation models show no evidence of circulating dermal fibroblast progenitors in bleomycin-induced skin fibrosis.
Boban I; Barisic-Dujmovic T; Clark SH
J Cell Physiol; 2008 Jan; 214(1):230-7. PubMed ID: 17579342
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.
Russo RC; Alessandri AL; Garcia CC; Cordeiro BF; Pinho V; Cassali GD; Proudfoot AE; Teixeira MM
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):72-80. PubMed ID: 20833968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
